Plunkett Research Online: Panbela Therapeutics Inc

PANBELA THERAPEUTICS INC (PBLA) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Panbela Therapeutics Inc is a clinical stage drug development company. It is engaged in the commercial development of a proprietary polyamine analogue for pancreatic cancer and for the second indication in chronic pancreatitis. The firm has developed a polyamine analogue compound referred as SBP-101.....


PANBELA THERAPEUTICS INC

Ticker: PBLA
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 952 479-1196
Fax:
Address: 712 Vista Boulevard
Waconia, MN 55387 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Jennifer SimpsonCEO/Director/President
Susan HorvathCFO/Chief Accounting Officer/Secretary/Treasurer/Vice President, Divisional
See More
Panbela Therapeutics Inc is a clinical stage drug development company. It is engaged in the commercial development of a proprietary polyamine analogue for pancreatic cancer and for the second indication in chronic pancreatitis. The firm has developed a polyamine analogue compound referred as SBP-101.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture